These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 15372593)

  • 21. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study.
    Aarsland D; Andersen K; Larsen JP; Lolk A; Kragh-Sørensen P
    Arch Neurol; 2003 Mar; 60(3):387-92. PubMed ID: 12633150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The rate of cognitive decline in Parkinson disease.
    Aarsland D; Andersen K; Larsen JP; Perry R; Wentzel-Larsen T; Lolk A; Kragh-Sørensen P
    Arch Neurol; 2004 Dec; 61(12):1906-11. PubMed ID: 15596611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cognition deterioration in Parkinson's disease: associated risk factors].
    Errea JM; Ara JR
    Rev Neurol; 1999 Mar 1-15; 28(5):439-43. PubMed ID: 10229953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term cognitive profile and incidence of dementia after STN-DBS in Parkinson's disease.
    Aybek S; Gronchi-Perrin A; Berney A; Chiuvé SC; Villemure JG; Burkhard PR; Vingerhoets FJ
    Mov Disord; 2007 May; 22(7):974-81. PubMed ID: 17443691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective follow-up study between 3 and 15 months after stroke: improvements and decline in cognitive function among dementia-free stroke survivors >75 years of age.
    Ballard C; Rowan E; Stephens S; Kalaria R; Kenny RA
    Stroke; 2003 Oct; 34(10):2440-4. PubMed ID: 14512580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A controlled, longitudinal study of dementia in Parkinson's disease.
    Biggins CA; Boyd JL; Harrop FM; Madeley P; Mindham RH; Randall JI; Spokes EG
    J Neurol Neurosurg Psychiatry; 1992 Jul; 55(7):566-71. PubMed ID: 1640232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
    Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
    Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hippocampal volume and white matter disease in the prediction of dementia in Parkinson's disease.
    Kandiah N; Zainal NH; Narasimhalu K; Chander RJ; Ng A; Mak E; Au WL; Sitoh YY; Nadkarni N; Tan LC
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1203-8. PubMed ID: 25258331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease.
    Giladi N; Treves TA; Paleacu D; Shabtai H; Orlov Y; Kandinov B; Simon ES; Korczyn AD
    J Neural Transm (Vienna); 2000; 107(1):59-71. PubMed ID: 10809404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parkinson's disease dementia: definitions, guidelines, and research perspectives in diagnosis.
    Goetz CG; Emre M; Dubois B
    Ann Neurol; 2008 Dec; 64 Suppl 2():S81-92. PubMed ID: 19127578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive profile of patients with newly diagnosed Parkinson disease.
    Muslimovic D; Post B; Speelman JD; Schmand B
    Neurology; 2005 Oct; 65(8):1239-45. PubMed ID: 16247051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Motor impairment in PD: relationship to incident dementia and age.
    Levy G; Tang MX; Cote LJ; Louis ED; Alfaro B; Mejia H; Stern Y; Marder K
    Neurology; 2000 Aug; 55(4):539-44. PubMed ID: 10953188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parkinson's disease dementia: Diagnostic criteria and risk factor review.
    Vasconcellos LF; Pereira JS
    J Clin Exp Neuropsychol; 2015; 37(9):988-93. PubMed ID: 26332178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive impairments in advanced PD without dementia.
    Green J; McDonald WM; Vitek JL; Evatt M; Freeman A; Haber M; Bakay RA; Triche S; Sirockman B; DeLong MR
    Neurology; 2002 Nov; 59(9):1320-4. PubMed ID: 12427877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of dementia after Parkinson's disease in Taiwan: a population-based retrospective cohort study using National Health Insurance claims.
    Liu CC; Sun Y; Lee PC; Li CY; Hu SC
    BMJ Open; 2019 Mar; 9(3):e025274. PubMed ID: 30833322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sleep spindles in Parkinson's disease may predict the development of dementia.
    Latreille V; Carrier J; Lafortune M; Postuma RB; Bertrand JA; Panisset M; Chouinard S; Gagnon JF
    Neurobiol Aging; 2015 Feb; 36(2):1083-90. PubMed ID: 25442116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cognitive dysfunction in patients with Parkinson's disease].
    Zakharov VV; Iakhno NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(1):13-9. PubMed ID: 15704477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dementia in Parkinson's disease: Is male gender a risk factor?
    Cereda E; Cilia R; Klersy C; Siri C; Pozzi B; Reali E; Colombo A; Zecchinelli AL; Mariani CB; Tesei S; Canesi M; Sacilotto G; Meucci N; Zini M; Isaias IU; Barichella M; Cassani E; Goldwurm S; Pezzoli G
    Parkinsonism Relat Disord; 2016 May; 26():67-72. PubMed ID: 26952697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does anxiety affect risk of dementia? Findings from the Caerphilly Prospective Study.
    Gallacher J; Bayer A; Fish M; Pickering J; Pedro S; Dunstan F; Ebrahim S; Ben-Shlomo Y
    Psychosom Med; 2009 Jul; 71(6):659-66. PubMed ID: 19553290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Executive dysfunction in non-demented Parkinson's disease patients with hallucinations.
    Imamura K; Wada-Isoe K; Kitayama M; Nakashima K
    Acta Neurol Scand; 2008 Apr; 117(4):255-9. PubMed ID: 17922890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.